Modulation of dendritic cell alternative activation and function by the vitamin A metabolite retinoic acid

4Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

The archetypal Th2 cytokine IL-4 has previously been shown to alternatively activate murine macrophages and, more recently, dendritic cells (DCs) both in vitro and in vivo. IL-4 has also been shown to induce Aldh1a2 (aldehyde dehydrogenase 1a2) expression in murine macrophages recruited to the peritoneal cavity. However, the influence of IL-4 on DC Aldh1a2 induction in vivo has not yet been addressed. In this work, we found that DCs show enhanced aldehyde dehydrogenase enzyme activity in vivo, which led us to investigate the impact of the vitamin A metabolite all-trans retinoic acid (RA) on DC alternative activation and function. Antagonism of RA receptors reduced production of resistin-like molecule alpha by DCs responding to IL-4, while addition of exogenous RA enhanced production of this marker of alternative activation. Functionally, RA increased DC induction of CD4+ T-cell IL-10, while reducing CD4+ T-cell IL-4 and IL-13, revealing a previously unidentified role for RA in regulating the ability of alternatively activated DCs to influence Th2 polarization.

Author supplied keywords

Cite

CITATION STYLE

APA

Jones, L. H., Cook, P. C., Ivens, A. C., Thomas, G. D., Phythian-Adams, A. T., Allen, J. E., & MacDonald, A. S. (2015). Modulation of dendritic cell alternative activation and function by the vitamin A metabolite retinoic acid. International Immunology, 27(11), 589–596. https://doi.org/10.1093/intimm/dxv020

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free